Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement regarding Board Meeting intimation: Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith copies of newspaper advertisement published in Free Press Journal (English daily) and Navshakti (Marathi daily), Mumbai editions, both dated July 18, 2019 in which Notice for intimation of Board Meeting scheduled to be held on Friday, July 26, 2019 have been published.
19-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Friday, July 26, 2019.

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2019 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2019. Further, in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in accordance with Company's internal code of conduct for prevention of insider trading, the Trading Window for dealing in the securities of the Company has been closed for Directors / Officers and designated employees of the Company from July 1, 2019 and shall remain closed till the expiry of 48 hours from the announcement / declaration of un-audited financial results of the Company for the quarter ended June 30, 2019.
17-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Friday, July 26, 2019.

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2019 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2019. Further, in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in accordance with Company's internal code of conduct for prevention of insider trading, the Trading Window for dealing in the securities of the Company has been closed for Directors / Officers and designated employees of the Company from July 1, 2019 and shall remain closed till the expiry of 48 hours from the announcement / declaration of un-audited financial results of the Company for the quarter ended June 30, 2019.
17-07-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Intimation Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015.

 Details of Key Managerial Personnel ("KMP") for determining materiality under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of an event or information and for the purpose of making disclosures to stock exchange(s).
16-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Resignation of Ms. Nikita Bavishi as Company Secretary & Compliance Officer of the company w.e.f. closure of business hours of 08th July, 2019. We request you to take the same on your records.
08-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Change in Directorate

 In terms of Regulation 30(2) read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Monday, 8th July, 2019 has approved the appointment of Mr. Prashant J. Pandit (DIN: 03079878) as an Additional Non-Executive Independent Director w.e.f. 8th July, 2019. We request you to take the same on your records.
08-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Outcome of Board Meeting

 Outcome of the Board Meeting held on 8th July, 2019
08-07-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nikita BavishiDesignation :- Company Secretary and Compliance Officer
06-07-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

 Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and Company's Code for prevention of Insider Trading by Designated Persons, the Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons from 01st July, 2019 till the expiry of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended 30th June 2019. Kindly take the above information on your record.
29-06-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aaditya R Dhoot
28-06-2019
Next Page
Close

Let's Open Free Demat Account